EP-42675
UNII DUM42I2BVP

Substance Identification & Data

This profile provides standardized clinical and technical data for Ep-42675, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DUM42I2BVP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 343776-67-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DUM42I2BVP

CAS Registry Number

343776-67-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EP-42675

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C79H117N7O56S7.8Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

DFRCPVPOZMLZGH-KIDSDGJESA-F

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

11600660

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O([C@@H]1[C@@H](COS([O-])(=O)=O)O[C@H](O[C@]2([H])[C@H](C(=O)[O-])O[C@@H](O[C@]3([H])[C@@H](COS([O-])(=O)=O)O[C@H](OC)[C@H](OS([O-])(=O)=O)[C@H]3OC)[C@H](OC)[C@H]2OC)[C@H](OS([O-])(=O)=O)[C@H]1OS([O-])(=O)=O)[C@]4([H])O[C@H](C(=O)[O-])[C@@H](O[C@@]5([H])O[C@H](COS([O-])(=O)=O)[C@@H](OCCOCCOCCOCCNC(=O)CCCNC(=O)C[C@@H](C(=O)N[C@@H](C(N6CCCCC6)=O)Cc7ccc(C(N)=N)cc7)NS(c8c(C)cc(OC)c(C)c8C)(=O)=O)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ep-42675. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(2S,3S,4S,5R,6R)-3-((2R,3R,4S,5R,6R)-5-(2-(2-(2-(2-(4-(((3S)-4-(((1R)-1-((4-CARBAMIMIDOYLPHENYL)METHYL)-2-OXO-2-(1-PIPERIDYL)ETHYL)AMINO)-3-((4-METHOXY-2,3,6-TRIMETHYL-PHENYL)SULFONYLAMINO)-4-OXO-BUTANOYL)AMINO)BUTANOYLAMINO)ETHOXY)ETHOXY)ETHOXY)ETHOXY)-3,4-DIMETHOXY-6-(SULFOOXYMETHYL)TETRAHYDROPYRAN-2-YL)OXY-6-((2R,3R,4S,5R,6R)-6-((2R,3S,4S,5R,6R)-2-CARBOXY-6-((2R,3R,4S,5R,6S)-4,6-DIMETHOXY-5-SULFOOXY-2-(SULFOOXYMETHYL)TETRAHYDROPYRAN-3-YL)OXY-4,5-DIMETHOXY-TETRAHYDROPYRAN-3-YL)OXY-4,5-DISULFOOXY-2-(SULFOOXYMETHYL)TETRAHYDROPYRAN-3-YL)OXY-4,5-DIMETHOXY-TETRAHYDROPYRAN-2-CARBOXYLIC ACID SODIUM HYDRIDE

SYS

.ALPHA.-D-GLUCOPYRANOSIDE, METHYL O-4-O-((20S,23R)-23-((4-(AMINOIMINOMETHYL)PHENYL)METHYL)-20-(((4-METHOXY-2,3,6-TRIMETHYLPHENYL)SULFONYL)AMINO)-13,18,21,24-TETRAOXO-24-(1-PIPERIDINYL)-3,6,9-TRIOXA-12,17,22-TRIAZATETRACOS-1-YL)-2,3-DI-O-METHYL-6-O-SULFO-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-2,3-DI-O-METHYL-.BETA.-D-GLUCOPYRANURONOSYL-(1->4)-O-2,3,6-TRI-O-SULFO-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-2,3-DI-O-METHYL-.ALPHA.-L-IDOPYRANURONOSYL-(1->4)-3-O-METHYL-, 2,6-BIS(HYDROGEN SULFATE), SODIUM SALT (1:8)

SYS